mardi 4 décembre 2018

Onco Actu du 4 décembre 2018

1.4 Biologie - Technos

WHO looks at standards in "uncharted water" of gene editing [Reuters]

The CRISPR Baby Scandal Gets Worse by the Day [The Atlantic]

2.5 Etiologie - Gènes

Large-scale genomic study discovers 40 new genetic variants associated with colorectal cancer risk [Fred Hutch]

3. Prévention

Tailored Lifestyle Feedback Given During Colorectal Cancer Screening Improved Patients’ Health Behaviors [AACR]

5.1 Traitements - Pré-clinique

New drug combination could be more effective against melanoma [MIT News]

5.12 Immunothérapies

How Can We Turn “Cold” Pancreatic Tumors “Hot”? [Cancer Research Catalyst]

5.12.2 Immunothérapies - CAR-T, thérapies cellulaires

There Is a Magic Bullet for Some Cancers. What If It Misses? [Bloomberg]

5.2.1 Pharma - Partenariats

J&J shells out $500M to sew up Argenyx's blood cancer hopeful cusatuzumab [FierceBiotech]

J&J pays $500M in cash to grab rights to a new star cancer drug at argenx [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

Red tape preventing cancer patients from accessing new drugs [The Guardian]

Despite innovation, Europeans wait years for new cancer drugs [Reuters]

New cancer drugs taking longer to reach NHS patients [Institute of Cancer Research]

5.4 Traitements - Economie

‘A loss for the rest of us’: An FDA approval is a boon for a drug maker, but could come at a major cost for patients [STAT]

6.2 Implants mammaires

Breast implants and anaplastic large cell lymphoma [BMJ]